We are proud to introduce Daiichi Sankyo | DSPACE as a Gold Sponsor for Frontiers Health 2024!

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.

DSPACE serves as Daiichi Sankyo’s Digital Innovation Hub, representing the engagement at the forefront of digital innovation to leverage digital technologies for improved patient outcomes. DSPACE strategically complements Daiichi Sankyo Europe´s portfolio in cardiovascular and oncology – focusing on cardiovascular first. Daiichi Sankyo’s vision is to become an innovative global healthcare company. DSPACE serves as a crucial asset in this transformative journey.

Join us at Frontiers Health 2024 in Berlin on October 17-18 to meet the Daiichi Sankyo Europe | DSPACE team alongside other key industry players.